This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Mouse alpha-Fetoprotein/AFP Quantikine ELISA Kit
catalog :
MAFP00
quantity :
1 Kit
price :
655 USD
citations: 16
Reference
Chung J, Lee W, Lee O, Ylaya K, Nambiar D, Sheehan Klenk J, et al. Glypican-3 deficiency in liver cancer upregulates MAPK/ERK pathway but decreases cell proliferation. Am J Cancer Res. 2024;14:3348-3371 pubmed publisher
Schmithals C, Kakoschky B, Denk D, von Harten M, Klug J, Hintermann E, et al. Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice. EBioMedicine. 2024;105:105178 pubmed publisher
Zhang Y, Liu X, Sun K, Luo Y, Yang J, Li A, et al. Hyperpolarization-activated cyclic nucleotide-gated cation channel 3 promotes HCC development in a female-biased manner. Cell Rep. 2023;42:113157 pubmed publisher
Pan Y, Chen H, Zhang X, Liu W, Ding Y, Huang D, et al. METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy. Cell Rep Med. 2023;4:101144 pubmed publisher
Gerardo Ram xed rez M, Giam V, Becker D, Groth M, Hartmann N, Morrison H, et al. Deletion of Cd44 Inhibits Metastasis Formation of Liver Cancer in Nf2-Mutant Mice. Cells. 2023;12: pubmed publisher
Giri S, Bhoi B, Trivedi C, Rath A, Rathod R, Sharma A, et al. Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet. BMC Cancer. 2023;23:59 pubmed publisher
Abd El Fattah E, Saber S, Youssef M, Eissa H, El Ahwany E, Amin N, et al. AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma. Front Pharmacol. 2021;12:720173 pubmed publisher
Deust A, Chobert M, Démontant V, Gricourt G, Denaës T, Thiolat A, et al. Macrophage autophagy protects against hepatocellular carcinogenesis in mice. Sci Rep. 2021;11:18809 pubmed publisher
Di Giorgio E, Wang L, Xiong Y, Akimova T, Christensen L, Han R, et al. MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity. J Clin Invest. 2020;130:6242-6260 pubmed publisher
Damgaard R, Jolin H, Allison M, Davies S, Titheradge H, McKenzie A, et al. OTULIN protects the liver against cell death, inflammation, fibrosis, and cancer. Cell Death Differ. 2020;27:1457-1474 pubmed publisher
Matsuura K, Takami T, Maeda M, Hisanaga T, Fujisawa K, Saeki I, et al. Evaluation of the Effects of Cultured Bone Marrow Mesenchymal Stem Cell Infusion on Hepatocarcinogenesis in Hepatocarcinogenic Mice With Liver Cirrhosis. Transplant Proc. 2019;51:925-935 pubmed publisher
Jais P, Decroly E, Jacquet E, Le Boulch M, Jaïs A, Jean Jean O, et al. C3P3-G1: first generation of a eukaryotic artificial cytoplasmic expression system. Nucleic Acids Res. 2019;47:2681-2698 pubmed publisher
Fang C, Wu C, Liao Y, Huang S, Chen M, Chen Y. AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage. Sci Rep. 2018;8:13802 pubmed publisher
Cui G, Martin R, Jin H, Liu X, Pandit H, Zhao H, et al. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver. J Exp Clin Cancer Res. 2018;37:136 pubmed publisher
Singhal G, Kumar G, Chan S, Fisher F, Ma Y, Vardeh H, et al. Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet. Mol Metab. 2018;13:56-66 pubmed publisher
Ambade A, Satishchandran A, Gyöngyösi B, Lowe P, Szabo G. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease. World J Gastroenterol. 2016;22:4091-108 pubmed publisher
product information
master code :
MAFP00
SKU :
MAFP00
product name :
Mouse alpha-Fetoprotein/AFP Quantikine ELISA Kit
unit size :
1 Kit
description :
The Mouse alpha-Fetoprotein/AFP Quantikine ELISA Kit from R&D Systems is a Solid Phase Sandwich ELISA that quantifies mouse alpha-Fetoprotein/AFP in cell culture supernates (50 ul), serum (10 ul), edta plasma (10 ul), heparin plasma (10 ul).
target :
alpha-Fetoprotein/AFP
category :
ELISAs
species :
Mouse
specificity :
Natural and recombinant mouse AFP.
gene symbol :
Afp
kit type :
Solid Phase Sandwich ELISA
assay length :
4.5 hours
elisaSampleTypes :
Cell Culture Supernates (50 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL)
elisaSensitivity :
0.029 ng/mL
elisaRange :
0.16 - 10 ng/mL
top caption :
Mouse alpha-Fetoprotein/AFP ELISA Standard Curve
applications :
ELISA
USD :
655 USD
product details :
The Quantikine Mouse alpha -Fetoprotein/AFP Immunoassay is a 4.5 hour solid phase ELISA designed to measure mouse AFP levels in cell culture supernates, serum, and plasma. It contains NS0-expressed recombinant mouse AFP and antibodies raised against the recombinant factor. This immunoassay has been shown to quantitate the recombinant mouse AFP accurately. Results obtained using natural mouse AFP showed dose-response curves that were parallel to the standard curves obtained using the recombinant kit standards. These results indicate that this kit can be used to determine relative mass values for natural mouse AFP.
alt names :
AFP, Alpha-1-fetoprotein, Alpha-fetoglobulin, alpha-fetoprotein, DSCAM2, FETA, HP, HPAFP
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.